Pharmaceutical industry news
Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.
32,007 stories, page 10 of 534
πΊπΈResearchclinicaltrials.gov
NCT07796373: Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inhibitor or Pirtobrutinib and Previously Treated With a BCL2 Inhibitor
Study type: INTERVENTIONAL. Phase: PHASE2.
ClinicalTrials.govOriginal source
πΊπΈResearchclinicaltrials.gov
NCT06323161: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin
Study type: INTERVENTIONAL. Phase: PHASE3.
ClinicalTrials.govOriginal source
πΊπΈResearchclinicaltrials.gov
NCT05232071: Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus
Study type: INTERVENTIONAL. Phase: PHASE2.
ClinicalTrials.govOriginal source






